NCT07541755 2026-04-21PD1-VEN-CAGFujian Medical University Union HospitalPhase 3 Active not recruiting40 enrolled
NCT03907488 2026-04-13Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin LymphomaNational Cancer Institute (NCI)Phase 3 Active not recruiting994 enrolled 11 charts 3 FDA